ScholarIQanswers from OpenAlex
Centre Hospitalier Universitaire de Nantes
InstitutionResearch output, impact & collaborations
Centre Hospitalier Universitaire de Nantes is a institution indexed in ScholarIQ from OpenAlex.
What is known about Centre Hospitalier Universitaire de Nantes?
ScholarIQrecord summary
Centre Hospitalier Universitaire de Nantes is a research organisation in Nantes, FR. OpenAlex records 20,878 works and 1,157,995 citations for it. 4,458 researchers list it as their most recent affiliation.
How many works does Centre Hospitalier Universitaire de Nantes have?
ScholarIQindexed works
Centre Hospitalier Universitaire de Nantes has 20,878 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Centre Hospitalier Universitaire de Nantes have?
ScholarIQcitation count
Centre Hospitalier Universitaire de Nantes has 1,157,995 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Centre Hospitalier Universitaire de Nantes?
ScholarIQresearcher count
Centre Hospitalier Universitaire de Nantes has 4,458 researchers in the ScholarIQ index.
What is the average h-index at Centre Hospitalier Universitaire de Nantes?
ScholarIQavg h-index
Centre Hospitalier Universitaire de Nantes has an average h-index of 56.8 in OpenAlex.
What is the ROR of Centre Hospitalier Universitaire de Nantes?
ScholarIQror
The ROR for Centre Hospitalier Universitaire de Nantes is on the source record.
What is the OpenAlex record for Centre Hospitalier Universitaire de Nantes?
ScholarIQopenalex
The OpenAlex for Centre Hospitalier Universitaire de Nantes is on the source record.
Who are the most-cited researchers behind Centre Hospitalier Universitaire de Nantes?
ScholarIQtop researchers by citations
What are the most-cited papers on Centre Hospitalier Universitaire de Nantes?
ScholarIQmost cited works
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, С. В. Орлов, Chun‐Ming Tsai, Michael Boyer, Wu‐Chou Su, Jaafar Bennouna, Terufumi Kato, В. А. Горбунова, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schüler
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, Martin Sebastian, Sanjay Popat, Nobuyuki Yamamoto, Caicun Zhou, Cheng-Ping Hu, Kenneth J. O’Byrne, Jifeng Feng, Shun Lü, Yunchao Huang, Sarayut Lucien Geater, Kye Young Lee, Chun-Ming Tsai, В. А. Горбунова, Vera Hirsh, Jaafar Bennouna, С. В. Орлов, Tony Mok, Michael Boyer, Wu‐Chou Su, Ki Hyeong Lee, Terufumi Kato, Dan Massey, Mehdi Shahidi, Victoria Zazulina, Lecia V. Sequist
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Takashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
Djillali Annane, Alain Renault, Christian Brun‐Buisson, Bruno Mégarbane, Jean‐Pierre Quenot, Shidasp Siami, Alain Cariou, Xavier Forceville, Carole Schwebel, Claude Martin, Jean‐François Timsit, Benoît Misset, Mohamed Ali Benali, Gwenhaël Colin, Bertrand Souweine, Karim Asehnoune, Emmanuelle Mercier, Loïc Chimot, Claire Charpentier, Bruno François, Thierry Boulain, Franck Petitpas, Jean‐Michel Constantin, Gilles Dhonneur, François Baudin, Alain Combes, Julien Bohé, Jean-François Loriferne, Roland Amathieu, Fabrice Cook, Michel Slama, O. Leroy, Gilles Capellier, Auguste Dargent, Tarik Hissem, Virginie Maxime, Éric Bellissant
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
Élisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster, Virginie Westeel, Éric Pichon, A. Lavolé, Jérôme Dauba, D. Debieuvre, Pierre-Jean Souquet, L. Bigay-Gamé, Éric Dansin, M. Poudenx, Olivier Molinier, F. Vaylet, Denis Moro‐Sibilot, Dominique Herman, Jaafar Bennouna, Jean Trédaniel, A Ducoloné, Marie-Paule Lebitasy, Laurence Baudrin, Silvy Laporte, B. Milleron
How much of the research on Centre Hospitalier Universitaire de Nantes is open access?
ScholarIQopen access share
25%OPEN ACCESS